Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura

Clinical trial NCT04323748 · RECRUITING

Trial details

NCT number: NCT04323748
Sponsor: New York Medical College
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Immune Thrombocytopenic Purpura

Start date: 2021-02-24
Primary completion: 2026-07-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.